S-1/A ·Filed Mar 11, 2026
IPO registration amendment
Actionable Insight • Neutral
Monitor for the next amendment or pricing announcement, which may include offering range, use of proceeds, and financials. Until then, no actionable data is available.
Executive Summary
Analysis based on filing metadata only — document content was unavailable. This is an amended S-1 registration statement for Lakewood-Amedex Biotherapeutics Inc. (LABT), indicating the company is progressing toward an IPO, but no financial or operational details could be verified from the filing content.
Key Facts
- Company filed an S-1/A, an amended registration statement for an initial public offering.
- No financial or operational data could be extracted due to unavailability of filing content.
- Indicates ongoing preparation for IPO, but no material terms or performance metrics are confirmable.
Financial Impact
Not specified
Risk Factors
- Lack of transparency due to unavailable filing content increases information asymmetry risk.
- Biotech IPOs carry high execution and market risk, especially without disclosed financials or clinical data.
Investment Themes
Documents Analyzed
Report based on filing metadata.
8 reports for LABT
67% Hit rate @ T+20 Went positive at some point 2 of 3 best @ T+60▲ +88.01%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 25, 2026 4w ago | EFFECT | $1.67 $0.3100 | ▼ −81.44% | ▼ −79.96% | $0.2644 (−84.17%) |
Sep 18, 2026 5w ago | S-1 | $2.05 $0.5834 | ▲ +71.54% | ▲ +70.63% | $0.2644 (+87.10%) |
Jun 17, 2026 18w ago | 8-K | $0.6022 $0.1890 | ▼ −68.62% | ▼ −68.93% | $0.2644 (−56.09%) |
May 14, 2026 23w ago | EFFECT | $19.60 $7.70 | ▲ +60.71% | ▲ +59.86% | $0.2644 (+98.65%) |
May 6, 2026 24w ago | 3 | $33.00 $6.70 | ▼ −79.70% | ▼ −80.51% | $0.2644 (−99.20%) |
Apr 20, 2026 27w ago | EFFECT | — | awaiting T+20 | — | — |
Apr 1, 2026 29w ago | S-1/A | — | awaiting T+20 | — | — |
Mar 11, 2026 32w ago | S-1/A | — | awaiting T+20 | — | — |
Showing 8 of 8
US Market Status
Market Open — Closes in 3h 18m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers